After participating in this educational activity, attendees should be able to:

Objectives

1. Define patient populations at risk for Cryptococcal meningitis.

2. Identify guideline-supported therapies in the treatment of Cryptococcal meningitis

3. Discuss the literature behind appropriate dosing and monitoring for agents used to treat Cryptococcal meningitis

Faculty

Brandon Opitz, PharmD

PGY2 Infectious Diseases Pharmacy Resident
Pharmacist
Baystate Medical Center

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.